\n
<\/p> \n
El Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima) recomienda aprobar la solicitud de Autorizaci\u00f3n Sanitaria de Uso de Emergencia, para el medicamento Molnupiravir, desarrollado por la farmac\u00e9utica Merck Sharp and Dohme.<\/b> <\/p> \n
(Invima aprueba uso de la vacuna anticovid Zivifax).\u00a0 <\/p> \n
\u201cLuego de evaluar la data cient\u00edfica allegada por el interesado, encontrando un balance riesgo-beneficio aceptable en el momento actual de la pandemia, se aprueba con algunas caracter\u00edsticas especiales para su indicaci\u00f3n\u201d<\/i>, se\u00f1al\u00f3 el Invima. <\/p> \n
Cada c\u00e1psula contiene 200 mg de Molnupiravir (Lagevrio), la dosis recomendada para pacientes adultos es de cuatro c\u00e1psulas, durante 5 d\u00edas, con o sin alimentos.<\/b> <\/p> \n
Cabe resaltar que este medicamento se aprueba solo bajo f\u00f3rmula m\u00e9dica. <\/p> \n
Este antiviral es indicado para el tratamiento de enfermedad leve a moderada, para pacientes con pruebas PCR o ant\u00edgeno confirmada, tambi\u00e9n para adultos mayores que no est\u00e9n vacunados.<\/b> <\/p> \n
Est\u00e1 contraindicado para pacientes que requieran hospitalizaci\u00f3n. Adem\u00e1s su uso no debe ser mayor a 5 d\u00edas consecutivos. Ni se puede iniciar el tratamiento posterior a estos 5 d\u00edas con s\u00edntomas. <\/p> \n
(La historia que tiene en l\u00edos a empresa que traer\u00e1 nueva vacuna china).\u00a0 <\/p> \n
\u201cNo se recomienda su uso en pacientes que hayan presentado previamente la enfermedad\u201d,<\/i> se\u00f1al\u00f3 el Invima. <\/p> \n
Cabe resaltar que este antiviral ha sido adquirido en m\u00e1s de 30 pa\u00edses, entre los que se incluyen Australia, Canad\u00e1, Corea, Jap\u00f3n, Reino Unidos y Estados Unidos.<\/b> En Latinoam\u00e9rica, M\u00e9xico y Panam\u00e1 ya aprobaron su uso. <\/p> \n
As\u00ed como la Agencia Europea de Medicamentos y la Administraci\u00f3n de Alimentos y Medicamentos de Estados Unidos, FDA. <\/p> \n
Carmela Oranges, directora m\u00e9dica de Merck Sharp and Dohme, se\u00f1al\u00f3 que el antiviral tiene \u201cuna eficacia demostrada en la reducci\u00f3n del riesgo de muerte en un 89%\u201d.<\/i> <\/p> \n
Adem\u00e1s de evitar que el virus se replique en el organismo desencadenando una enfermedad grave. <\/p> \n
PORTAFOLIO <\/p> \n<\/div>\n
Fuente: Portafolio<\/a> <\/p> \n<\/div>","protected":false},"excerpt":{"rendered":"
El Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima) recomienda aprobar la solicitud de Autorizaci\u00f3n Sanitaria de Uso de Emergencia, para el medicamento Molnupiravir, … <\/p> \n","protected":false},"author":2,"featured_media":67960,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[1273],"tags":[3707,1170,7201,2148,7282],"yoast_head":"\n
Invima aprueba el uso de emergencia de antiviral Molnupiravir - El Papayaso<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invima aprueba el uso de emergencia de antiviral Molnupiravir\" \/>\n<meta property=\"og:description\" content=\"El Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima) recomienda aprobar la solicitud de Autorizaci\u00f3n Sanitaria de Uso de Emergencia, para el medicamento Molnupiravir, …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/\" \/>\n<meta property=\"og:site_name\" content=\"El Papayaso\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/papayaso.colombia\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-28T17:44:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-28T17:44:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/papayaso.co\/wp-content\/uploads\/2022\/01\/61f420d3e26bb.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:creator\" content=\"@Papayaso4\" \/>\n<meta name=\"twitter:site\" content=\"@Papayaso4\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/papayaso.co\/#organization\",\"name\":\"El Papayaso\",\"url\":\"https:\/\/papayaso.co\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/papayaso.colombia\",\"https:\/\/www.instagram.com\/el.papayaso\/\",\"https:\/\/twitter.com\/Papayaso4\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/papayaso.co\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/papayaso.co\/wp-content\/uploads\/2019\/03\/logo-header-megaphone.png\",\"contentUrl\":\"https:\/\/papayaso.co\/wp-content\/uploads\/2019\/03\/logo-header-megaphone.png\",\"width\":300,\"height\":94,\"caption\":\"El Papayaso\"},\"image\":{\"@id\":\"https:\/\/papayaso.co\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/papayaso.co\/#website\",\"url\":\"https:\/\/papayaso.co\/\",\"name\":\"El Papayaso\",\"description\":\"Te mantenemos conectado con la tierrita!\",\"publisher\":{\"@id\":\"https:\/\/papayaso.co\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/papayaso.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/papayaso.co\/wp-content\/uploads\/2022\/01\/61f420d3e26bb.jpeg\",\"contentUrl\":\"https:\/\/papayaso.co\/wp-content\/uploads\/2022\/01\/61f420d3e26bb.jpeg\",\"width\":600,\"height\":450},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#webpage\",\"url\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/\",\"name\":\"Invima aprueba el uso de emergencia de antiviral Molnupiravir - El Papayaso\",\"isPartOf\":{\"@id\":\"https:\/\/papayaso.co\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#primaryimage\"},\"datePublished\":\"2022-01-28T17:44:07+00:00\",\"dateModified\":\"2022-01-28T17:44:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/papayaso.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invima aprueba el uso de emergencia de antiviral Molnupiravir\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#webpage\"},\"author\":{\"@id\":\"https:\/\/papayaso.co\/#\/schema\/person\/22dc3f9e40998aac4193adb189f8cc2b\"},\"headline\":\"Invima aprueba el uso de emergencia de antiviral Molnupiravir\",\"datePublished\":\"2022-01-28T17:44:07+00:00\",\"dateModified\":\"2022-01-28T17:44:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#webpage\"},\"wordCount\":332,\"publisher\":{\"@id\":\"https:\/\/papayaso.co\/#organization\"},\"image\":{\"@id\":\"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/papayaso.co\/wp-content\/uploads\/2022\/01\/61f420d3e26bb.jpeg\",\"keywords\":[\"antiviral\",\"Coronavirus\",\"invima\",\"molnupiravir\",\"pastilla\"],\"articleSection\":[\"Econom\\u00eda\"],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/papayaso.co\/#\/schema\/person\/22dc3f9e40998aac4193adb189f8cc2b\",\"name\":\"Papaya\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/papayaso.co\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7b3a9a199283010272fb57590874317a?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7b3a9a199283010272fb57590874317a?s=96&r=g\",\"caption\":\"Papaya\"},\"sameAs\":[\"https:\/\/papayaso.co\"],\"url\":\"https:\/\/papayaso.co\/author\/adelgado\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Invima aprueba el uso de emergencia de antiviral Molnupiravir - El Papayaso","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/","og_locale":"en_US","og_type":"article","og_title":"Invima aprueba el uso de emergencia de antiviral Molnupiravir","og_description":"El Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Invima) recomienda aprobar la solicitud de Autorizaci\u00f3n Sanitaria de Uso de Emergencia, para el medicamento Molnupiravir, …","og_url":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/","og_site_name":"El Papayaso","article_publisher":"https:\/\/www.facebook.com\/papayaso.colombia","article_published_time":"2022-01-28T17:44:07+00:00","article_modified_time":"2022-01-28T17:44:11+00:00","og_image":[{"width":600,"height":450,"url":"https:\/\/papayaso.co\/wp-content\/uploads\/2022\/01\/61f420d3e26bb.jpeg","type":"image\/jpeg"}],"twitter_card":"summary","twitter_creator":"@Papayaso4","twitter_site":"@Papayaso4","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/papayaso.co\/#organization","name":"El Papayaso","url":"https:\/\/papayaso.co\/","sameAs":["https:\/\/www.facebook.com\/papayaso.colombia","https:\/\/www.instagram.com\/el.papayaso\/","https:\/\/twitter.com\/Papayaso4"],"logo":{"@type":"ImageObject","@id":"https:\/\/papayaso.co\/#logo","inLanguage":"en-US","url":"https:\/\/papayaso.co\/wp-content\/uploads\/2019\/03\/logo-header-megaphone.png","contentUrl":"https:\/\/papayaso.co\/wp-content\/uploads\/2019\/03\/logo-header-megaphone.png","width":300,"height":94,"caption":"El Papayaso"},"image":{"@id":"https:\/\/papayaso.co\/#logo"}},{"@type":"WebSite","@id":"https:\/\/papayaso.co\/#website","url":"https:\/\/papayaso.co\/","name":"El Papayaso","description":"Te mantenemos conectado con la tierrita!","publisher":{"@id":"https:\/\/papayaso.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/papayaso.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#primaryimage","inLanguage":"en-US","url":"https:\/\/papayaso.co\/wp-content\/uploads\/2022\/01\/61f420d3e26bb.jpeg","contentUrl":"https:\/\/papayaso.co\/wp-content\/uploads\/2022\/01\/61f420d3e26bb.jpeg","width":600,"height":450},{"@type":"WebPage","@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#webpage","url":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/","name":"Invima aprueba el uso de emergencia de antiviral Molnupiravir - El Papayaso","isPartOf":{"@id":"https:\/\/papayaso.co\/#website"},"primaryImageOfPage":{"@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#primaryimage"},"datePublished":"2022-01-28T17:44:07+00:00","dateModified":"2022-01-28T17:44:11+00:00","breadcrumb":{"@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/papayaso.co\/"},{"@type":"ListItem","position":2,"name":"Invima aprueba el uso de emergencia de antiviral Molnupiravir"}]},{"@type":"Article","@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#article","isPartOf":{"@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#webpage"},"author":{"@id":"https:\/\/papayaso.co\/#\/schema\/person\/22dc3f9e40998aac4193adb189f8cc2b"},"headline":"Invima aprueba el uso de emergencia de antiviral Molnupiravir","datePublished":"2022-01-28T17:44:07+00:00","dateModified":"2022-01-28T17:44:11+00:00","mainEntityOfPage":{"@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#webpage"},"wordCount":332,"publisher":{"@id":"https:\/\/papayaso.co\/#organization"},"image":{"@id":"https:\/\/papayaso.co\/economia\/invima-aprueba-el-uso-de-emergencia-de-antiviral-molnupiravir\/#primaryimage"},"thumbnailUrl":"https:\/\/papayaso.co\/wp-content\/uploads\/2022\/01\/61f420d3e26bb.jpeg","keywords":["antiviral","Coronavirus","invima","molnupiravir","pastilla"],"articleSection":["Econom\u00eda"],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/papayaso.co\/#\/schema\/person\/22dc3f9e40998aac4193adb189f8cc2b","name":"Papaya","image":{"@type":"ImageObject","@id":"https:\/\/papayaso.co\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/7b3a9a199283010272fb57590874317a?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7b3a9a199283010272fb57590874317a?s=96&r=g","caption":"Papaya"},"sameAs":["https:\/\/papayaso.co"],"url":"https:\/\/papayaso.co\/author\/adelgado\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/posts\/67959"}],"collection":[{"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/comments?post=67959"}],"version-history":[{"count":1,"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/posts\/67959\/revisions"}],"predecessor-version":[{"id":67961,"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/posts\/67959\/revisions\/67961"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/media\/67960"}],"wp:attachment":[{"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/media?parent=67959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/categories?post=67959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/papayaso.co\/wp-json\/wp\/v2\/tags?post=67959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}